Insulin
*Prices reflect U.S. average retail price
NPH insulin, also known as isophane insulin, is an intermediate–acting insulin given to help control blood sugar levels in people with diabetes. It is used by injection under the skin once to twice a day. Onset of effects is typically in 90 minutes and they last for 24 hours. Versions are available that come premixed with a short–acting insulin, such as regular insulin... Wikipedia
Manufacturer's Website: Not Available Average retail cost: $25/vial
Novolin 70/30, an insulin preparation containing mixed NPH and regular insulin, respectively... Wikipedia
Manufacturer's Website: Not Available Average retail cost: $146/vial
Insulin aspart is a fast-acting insulin analog marketed by Novo Nordisk as NovoLog/NovoRapid. It is a manufactured form of human insulin; where a single amino acid has been exchanged. This change helps the fast-acting insulin analog be absorbed quickly into the bloodstream. As a result, it starts working in minutes, which allows one to take insulin and eat right away. Fast-acting insulin analogs are considered to act similarly to the way insulin is released in people without diabetes mellitus... Wikipedia
Manufacturer's Website: Novolog Average retail cost: $152/pen
Regular insulin, also known as neutral insulin and soluble insulin is a type of short acting insulin. It is used to treat diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states. It is also used along with glucose to treat high blood potassium levels... Wikipedia
Manufacturer's Website: Not Available Average retail cost: $159/vial
Novolin 70/30, an insulin preparation containing mixed NPH and regular insulin, respectively... Wikipedia
Manufacturer's Website: Not Available Average retail cost: $163/vial
NPH insulin, also known as isophane insulin, is an intermediate–acting insulin given to help control blood sugar levels in people with diabetes. It is used by injection under the skin once to twice a day. Onset of effects is typically in 90 minutes and they last for 24 hours. Versions are available that come premixed with a short–acting insulin, such as regular insulin... Wikipedia
Manufacturer's Website: Not Available Average retail cost: $174/vial
Regular insulin, also known as neutral insulin and soluble insulin is a type of short acting insulin. It is used to treat diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states. It is also used along with glucose to treat high blood potassium levels. Typically it is given by injection under the skin, but may also be used by injection into a vein or muscle. Onset of effect is typically in 30 minutes and they last for 8 hours... Wikipedia
Manufacturer's Website: Humulin R Average retail cost: $181/vial
NPH insulin, also known as isophane insulin, is an intermediate–acting insulin given to help control blood sugar levels in people with diabetes. It is used by injection under the skin once to twice a day. Onset of effects is typically in 90 minutes and they last for 24 hours... Wikipedia
Manufacturer's Website: Humulin N Average retail cost: $181/vial
Admelog is a rapid-acting insulin similar to Humalog®, another insulin lispro 100 Units/mL, currently approved in the U.S. The Admelog clinical development program involved more than 1,000 adults living with type 1 or type 2 diabetes. Admelog will be available in both vials and the SoloStar pen, which is the most-used disposable insulin pen platform in the U.S.
Manufacturer's Website: Admelog Average retail cost: $214/vial
Insulin lispro, sold under the brand name Humalog among others, is a fast acting insulin analog. It was first approved for use in the United States in 1996, making it the first insulin analog to enter the market... Wikipedia
Manufacturer's Website: Humalog Average retail cost: $346/vial
Insulin aspart is a fast-acting insulin analog marketed by Novo Nordisk as NovoLog/NovoRapid. It is a manufactured form of human insulin; where a single amino acid has been exchanged. This change helps the fast-acting insulin analog be absorbed quickly into the bloodstream. As a result, it starts working in minutes, which allows one to take insulin and eat right away. Fast-acting insulin analogs are considered to act similarly to the way insulin is released in people without diabetes mellitus... Wikipedia
Manufacturer's Website: Novolog Average retail cost: $367/vial
Insulin aspart is a fast-acting insulin analog marketed by Novo Nordisk as NovoLog/NovoRapid. It is a manufactured form of human insulin; where a single amino acid has been exchanged. This change helps the fast-acting insulin analog be absorbed quickly into the bloodstream. As a result, it starts working in minutes, which allows one to take insulin and eat right away. Fast-acting insulin analogs are considered to act similarly to the way insulin is released in people without diabetes mellitus... Wikipedia
Manufacturer's Website: Novolog Average retail cost: $386/vial
Insulin lispro, sold under the brand name Humalog among others, is a fast acting insulin analog. It was first approved for use in the United States in 1996, making it the first insulin analog to enter the market... Wikipedia
Manufacturer's Website: Humalog Average retail cost: $406/vial
Insulin glargine, marketed under the names Basaglar, among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabete...Wikipedia
Manufacturer's Website: Basaglar Average retail cost: $465/carton
Insulin glargine, marketed under the names Lantus, among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes...Wikipedia
Manufacturer's Website: Toujeo Average retail cost: $472/carton
Insulin glargine, marketed under the names Lantus, among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes...Wikipedia
Manufacturer's Website: Toujeo Average retail cost: $489/carton
Insulin glargine, marketed under the names Lantus, among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile... Wikipedia
Manufacturer's Website: Lantus Average retail cost: $500/5 pens
Insulin lispro, sold under the brand name Humalog among others, is a fast acting insulin analog. It was first approved for use in the United States in 1996, making it the first insulin analog to enter the market... Wikipedia
Manufacturer's Website: Humalog Average retail cost: $523/carton
Insulin glargine, marketed under the names Lantus, among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile... Wikipedia
Manufacturer's Website: Lantus Average retail cost: $526/vial
Inhalable insulin is a powdered form of insulin, delivered with a nebulizer into the lungs where it is absorbed, generally more rapidly than subcutaneous insulin. Exubera, developed by Inhale Therapeutics (later named Nektar Therapeutics), became the first inhaled insulin product to be marketed in 2006 by Pfizer, but poor sales led Pfizer to withdraw it in 2007. Afrezza, a monomeric inhaled insulin developed by Mannkind, was approved by the FDA in 2014... Wikipedia
Manufacturer's Website: Afrezza Average retail cost: $526/kit
Insulin detemir is a long-acting human insulin analogue for maintaining the basal level of insulin. Novo Nordisk markets it under the trade name Levemir. It is an insulin analogue in which a fatty acid (myristic acid) is bound to the lysine amino acid at position B29. It is quickly absorbed after which it binds to albumin in the blood through its fatty acid at position B29. It then slowly dissociates from this complex... Wikipedia
Manufacturer's Website: Levemir Average retail cost: $555/vial
Insulin lispro, sold under the brand name Humalog among others, is a fast acting insulin analog. It was first approved for use in the United States in 1996, making it the first insulin analog to enter the market... Wikipedia
Manufacturer's Website: Humalog Average retail cost: $647/5 pens
Insulin lispro, sold under the brand name Humalog among others, is a fast acting insulin analog. It was first approved for use in the United States in 1996, making it the first insulin analog to enter the market... Wikipedia
Manufacturer's Website: Humalog Average retail cost: $673/5 pens
Fiasp® is a formulation of insulin aspart with 2 excipients added. The active molecule in Fiasp® is identical to NovoLog®. The Fiasp® formulation contains the addition of niacinamide (vitamin B3) and a formulation-stabilizing amino acid (L-Arginine).
Manufacturer's Website: Fiasp Average retail cost: $677/vial
Insulin glulisine is a rapid-acting insulin analogue that differs from human insulin in that the amino acid asparagine at position B3 is replaced by lysine and the lysine in position B29 is replaced by glutamic acid. It was developed by Sanofi-Aventis and is sold under the trade name Apidra. When injected subcutaneously, it appears in the blood earlier than human insulin... Wikipedia
Manufacturer's Website: Apidra Average retail cost: $678/carton
Insulin aspart is a fast-acting insulin analog marketed by Novo Nordisk as NovoLog/NovoRapid. It is a manufactured form of human insulin; where a single amino acid has been exchanged. This change helps the fast-acting insulin analog be absorbed quickly into the bloodstream. As a result, it starts working in minutes, which allows one to take insulin and eat right away. Fast-acting insulin analogs are considered to act similarly to the way insulin is released in people without diabetes mellitus... Wikipedia
Manufacturer's Website: Novolog Average retail cost: $682/carton
Insulin degludec (INN/USAN) is an ultralong-acting basal insulin analogue that was developed by Novo Nordisk under the brand name Tresiba. It is administered via subcutaneous injection once daily to help control the blood sugar level of those with diabetes. It has a duration of action that lasts up to 42 hours (compared to 18 to 26 hours provided by other marketed long-acting insulins such as insulin glargine and insulin detemir), making it a once-daily basal insulin, that is one that provides a base insulin level, as opposed to the fast and short acting bolus insulins... Wikipedia
Manufacturer's Website: Tresiba Average retail cost: $695/carton
Insulin lispro, sold under the brand name Humalog among others, is a fast acting insulin analog. It was first approved for use in the United States in 1996, making it the first insulin analog to enter the market... Wikipedia
Manufacturer's Website: Humalog Average retail cost: $1,078/carton
Myxredlin is part of the Insulin Antagonists class and treats Diabetes Type 2 and Diabetes Type 1. Insulin antagonists are used to treat hypoglycemia. They work by increasing glucose to raise blood sugar levels. Myxredlin is only available as a brand name drug.
Manufacturer's Website: Myxredlin Average retail cost: *
* This prescription is provided by your healthcare provider. It cannot be filled in a pharmacy and may be expensive.
RYZODEG 70/30 is an insulin analog indicated to improve glycemic control11 in adults with diabetes mellitus.
Manufacturer's Website: Ryzoberg Average retail cost: *
*Ryzodeg has been approved by the FDA, but isn't available yet.
Humulin 70 / 30 (insulin isophane/insulin regular)
No longer available.
Humulin N Pen (insulin isophane)
No longer available.
Copyright 2006---2023 Automated Clinical Guidelines, LLC. All rights reserved.
